Litcius/Paper detail

Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study

Cheng-Teng Ip, Sebastian Olbrich, Melanie Ganz, Brice Ozenne, Kristin Köhler‐Forsberg, Vibeke H. Dam, Sándor Beniczky, Martin Balslev Jørgensen, Vibe G. Frøkjær, Birgitte Søgaard, Søren Rahn Christensen, Gitte M. Knudsen

2021European Neuropsychopharmacology35 citationsDOI

Topics & Concepts

Major depressive disorderAnterior cingulate cortexElectroencephalographyBiomarkerAntidepressantClinical trialPsychologyAlpha (finance)Internal medicineMedicineOncologyPsychiatryClinical psychologyMoodPsychometricsCognitionConstruct validityChemistryBiochemistryHippocampusEEG and Brain-Computer InterfacesFunctional Brain Connectivity StudiesNeural and Behavioral Psychology Studies
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study | Litcius